text
stringlengths 1
194
|
---|
α, increased interleukin-6 (IL-6), and did not affect IL-1
|
The coexistence of these risk factors may overshadow the
|
and captopril on lipid parameters in patients with type II diabetes
|
ISSN 1064-1963 print/1525-6006 online
|
untreated hypertensive patients and tested two different
|
0.89 � 0.12
|
The patients who did not smoke nor had caffeinated
|
cholesterol level: a meta-analysis of population-based prospective
|
angiotensin II receptor antagonists. Blood Press Suppl 2001;
|
Systolic and diastolic BP were significantly decreased
|
For personal use only.
|
HDL, TG, and TC levels. We do not know whether this is
|
Clinical and Experimental Hypertension
|
concentrations
|
that pose a risk for cardiovascular disease are important for
|
of an alpha-adrenergic blocker and an inhibitor of the angiotensin
|
Abbreviations: HDL – high density lipoprotein; LDL – low density
|
The study was conducted in Departments of Internal
|
Angiology 2009; 60(2):217–220.
|
6/16
|
losartan on insulin sensitivity, lipid profile, and endothelin in
|
drugs.
|
sympathoadrenal system. N Engl J Med 1996; 8(334):374–381.
|
© 2013 Informa Healthcare USA, Inc.
|
patients with type 2 diabetes or nephropathy (20).
|
LDL-Lowering Effect of Amlodipine
|
lipid profile (2,3). Data from our study also confirm the
|
.421
|
These findings are in accordance with previous reports
|
main limitation of our study is the small sample size and
|
GROUP
|
.702
|
AU2700 auto analyzer using reagents from Olympus
|
Patients of the two groups were matched for age and
|
unknown. The issue needs to be examined with further
|
12 weeks of antihypertensive therapy with amlodipine on
|
serum TC, TG, HDL, LDL (Figure 1), urea, creatinine, uric acid, aspartate aminotransferase, alanine aminotransferase, and hemoglobin levels, white blood cell
|
Clin Exp Hypertens Downloaded from informahealthcare.com by Nyu Medical Center on 10/16/14
|
7227 � 1249 .533
|
449
|
classes of antihypertensive drugs at the same time. The
|
.633
|
Amlodipine, a member of the calcium antagonists of the
|
It is clear from the present study that different antihypertensives have different effects on serum lipids in newly diagnosed hypertension. Valsartan may have deleterious effects
|
Differential effects of amlodipine and atorvastatin treatment and
|
219.3 � 58.5
|
.631
|
J Clin Hypertens 2006; 8(8):571–581.
|
atorvastatin treatment alone. The authors expressed that
|
[15] Jeppesen J, Hein H, Suadicani P, Gyntelberg F. Relation of high
|
lipopolysaccharide
|
Sait Demirkol,3 Fatih Bulucu,2 Kenan Saglam2
|
Hemoglobin (g/dL)
|
158.45 � 10.7
|
is associated with reduced insulin sensitivity and hyperinsulinemia, which in turn may cause dyslipidemia
|
Zekeriya Arslan,1 Seyit Ahmet Ay,2 Murat Karaman,2 Mustafa Cakar,2 Turgay Celik,3
|
WBC (�10/ L)
|
and after treatment were 93.0 � 8.7 and 75.6 �
|
(8,9). The last mentioned drugs were neutral for lipid
|
223.6 � 33.5
|
Age (y)
|
concentration of low-density lipoprotein cholesterol in plasma,
|
Angiotensin-2 receptor antagonists, which block
|
into valsartan group and 21 patients into the amlodipine
|
were recommended to make lifestyle modifications consisting of regular exercise, weight control, and salt restriction. All participants gave written informed consent. The
|
a holistic approach. From this perspective, the possible
|
Clin Exp Hypertens Downloaded from informahealthcare.com by Nyu Medical Center on 10/16/14
|
[8] Fernández PC, Luque OM, Martell CN, et al. Treatment of
|
lipoprotein.
|
Table 3. The serum lipid parameters of the valsartan group at
|
II receptor blockade on insulin sensitivity and sympathetic
|
Statistical Analysis
|
content and writing of this article.
|
laboratory
|
Z. Arslan et al.
|
127.3 � 29.2
|
.732
|
© 2013 Informa Healthcare USA, Inc.
|
antihypertensive drug therapy should also be considered
|
1999;
|
is also used to treat coronary artery disease, angina pectoris
|
Antihypertensive drugs are known to have different
|
12th week
|
in the metabolic effects of the angiotensin receptor blockers.
|
the valsartan group has been reported to decrease TC
|
Hypertens 1993; 6(11):303–308.
|
performed on 43 patients with newly diagnosed essential hypertension (group A, n = 21 and group B, n = 22).
|
with a significant reduction of LDL compared to valsartan. In the treatment of hypertension, prior knowledge of the plasma
|
[4] Keane W, Eknoyan G. Proteinuria, albuminuria, risk, assessment,
|
diseases (2), and high triglyceride (TG) and low-density
|
HDL cholesterol (mg/dL)
|
essential arterial hypertension with hypercholesterolemia. Effects
|
[21] Burnier M, Maillard M. The comparative pharmacology of
|
150.6 � 75.4
|
47.7 � 12.1
|
For personal use only.
|
important in the antihypertensive drug choice. Further
|
with evidence of any target organ damage from high
|
.328
|
LDL 12th week (mg/dL)
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.